Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Gene Therapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bluebird Bio
Dimension Therapeutics
Spark Therapeutics
Sangamo
Avalanche Bio
Advantagene
Celladon
Vical Inc.
By Type:
In Vivo
Ex Vivo
By End-User:
Cardiovascular Diseases
Infectious Diseases
Monogenic Diseases
Cancer Diseases
Others
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Gene Therapy Market
-
1.3 Market Segment by Type
1.3.1 Japan Gene Therapy Market Size and Growth Rate of In Vivo from 2014 to 2026
1.3.2 Japan Gene Therapy Market Size and Growth Rate of Ex Vivo from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Gene Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
1.4.2 Japan Gene Therapy Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
1.4.3 Japan Gene Therapy Market Size and Growth Rate of Monogenic Diseases from 2014 to 2026
1.4.4 Japan Gene Therapy Market Size and Growth Rate of Cancer Diseases from 2014 to 2026
1.4.5 Japan Gene Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Gene Therapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Gene Therapy by Major Types
3.4.1 Market Size and Growth Rate of In Vivo
3.4.2 Market Size and Growth Rate of Ex Vivo
4 Segmentation of Gene Therapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Gene Therapy by Major End-Users
4.4.1 Market Size and Growth Rate of Gene Therapy in Cardiovascular Diseases
4.4.2 Market Size and Growth Rate of Gene Therapy in Infectious Diseases
4.4.3 Market Size and Growth Rate of Gene Therapy in Monogenic Diseases
4.4.4 Market Size and Growth Rate of Gene Therapy in Cancer Diseases
4.4.5 Market Size and Growth Rate of Gene Therapy in Others
5 Market Analysis by Regions
-
5.1 Japan Gene Therapy Production Analysis by Regions
-
5.2 Japan Gene Therapy Consumption Analysis by Regions
6 Hokkaido Gene Therapy Landscape Analysis
-
6.1 Hokkaido Gene Therapy Landscape Analysis by Major Types
-
6.2 Hokkaido Gene Therapy Landscape Analysis by Major End-Users
7 Tohoku Gene Therapy Landscape Analysis
-
7.1 Tohoku Gene Therapy Landscape Analysis by Major Types
-
7.2 Tohoku Gene Therapy Landscape Analysis by Major End-Users
8 Kanto Gene Therapy Landscape Analysis
-
8.1 Kanto Gene Therapy Landscape Analysis by Major Types
-
8.2 Kanto Gene Therapy Landscape Analysis by Major End-Users
9 Chubu Gene Therapy Landscape Analysis
-
9.1 Chubu Gene Therapy Landscape Analysis by Major Types
-
9.2 Chubu Gene Therapy Landscape Analysis by Major End-Users
10 Kinki Gene Therapy Landscape Analysis
-
10.1 Kinki Gene Therapy Landscape Analysis by Major Types
-
10.2 Kinki Gene Therapy Landscape Analysis by Major End-Users
11 Chugoku Gene Therapy Landscape Analysis
-
11.1 Chugoku Gene Therapy Landscape Analysis by Major Types
-
11.2 Chugoku Gene Therapy Landscape Analysis by Major End-Users
12 Shikoku Gene Therapy Landscape Analysis
-
12.1 Shikoku Gene Therapy Landscape Analysis by Major Types
-
12.2 Shikoku Gene Therapy Landscape Analysis by Major End-Users
13 Kyushu Gene Therapy Landscape Analysis
-
13.1 Kyushu Gene Therapy Landscape Analysis by Major Types
-
13.2 Kyushu Gene Therapy Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Bluebird Bio
14.1.1 Bluebird Bio Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Dimension Therapeutics
14.2.1 Dimension Therapeutics Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Spark Therapeutics
14.3.1 Spark Therapeutics Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Sangamo
14.4.1 Sangamo Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Avalanche Bio
14.5.1 Avalanche Bio Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Advantagene
14.6.1 Advantagene Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Celladon
14.7.1 Celladon Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Vical Inc.
14.8.1 Vical Inc. Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
The List of Tables and Figures (Totals 123 Figures and 157 Tables)
Figure Japan Gene Therapy Market Size and Growth Rate of In Vivo from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Ex Vivo from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Monogenic Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Cancer Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Gene Therapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Gene Therapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Gene Therapy by Different Types from 2014 to 2026
-
Table Consumption Share of Gene Therapy by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of In Vivo
Figure Market Size and Growth Rate of Ex Vivo
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Gene Therapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of Gene Therapy by Different End-Users from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Infectious Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Monogenic Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Cancer Diseases from 2014 to 2026
Figure Japan Gene Therapy Market Size and Growth Rate of Others from 2014 to 2026
-
Table Japan Gene Therapy Production by Regions
-
Table Japan Gene Therapy Production Share by Regions
-
Figure Japan Gene Therapy Production Share by Regions in 2014
-
Figure Japan Gene Therapy Production Share by Regions in 2018
-
Figure Japan Gene Therapy Production Share by Regions in 2026
-
Table Japan Gene Therapy Consumption by Regions
-
Table Japan Gene Therapy Consumption Share by Regions
-
Figure Japan Gene Therapy Consumption Share by Regions in 2014
-
Figure Japan Gene Therapy Consumption Share by Regions in 2018
-
Figure Japan Gene Therapy Consumption Share by Regions in 2026
-
Table Hokkaido Gene Therapy Consumption by Types from 2014 to 2026
-
Table Hokkaido Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2014
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2018
-
Figure Hokkaido Gene Therapy Consumption Share by Types in 2026
-
Table Hokkaido Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2014
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2018
-
Figure Hokkaido Gene Therapy Consumption Share by End-Users in 2026
-
Table Tohoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Tohoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2014
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2018
-
Figure Tohoku Gene Therapy Consumption Share by Types in 2026
-
Table Tohoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Tohoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Kanto Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kanto Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Share by Types in 2014
-
Figure Kanto Gene Therapy Consumption Share by Types in 2018
-
Figure Kanto Gene Therapy Consumption Share by Types in 2026
-
Table Kanto Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kanto Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kanto Gene Therapy Consumption Share by End-Users in 2026
-
Table Chubu Gene Therapy Consumption by Types from 2014 to 2026
-
Table Chubu Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Share by Types in 2014
-
Figure Chubu Gene Therapy Consumption Share by Types in 2018
-
Figure Chubu Gene Therapy Consumption Share by Types in 2026
-
Table Chubu Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Chubu Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2014
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2018
-
Figure Chubu Gene Therapy Consumption Share by End-Users in 2026
-
Table Kinki Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kinki Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Share by Types in 2014
-
Figure Kinki Gene Therapy Consumption Share by Types in 2018
-
Figure Kinki Gene Therapy Consumption Share by Types in 2026
-
Table Kinki Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kinki Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kinki Gene Therapy Consumption Share by End-Users in 2026
-
Table Chugoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Chugoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2014
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2018
-
Figure Chugoku Gene Therapy Consumption Share by Types in 2026
-
Table Chugoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Chugoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Shikoku Gene Therapy Consumption by Types from 2014 to 2026
-
Table Shikoku Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2014
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2018
-
Figure Shikoku Gene Therapy Consumption Share by Types in 2026
-
Table Shikoku Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2014
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2018
-
Figure Shikoku Gene Therapy Consumption Share by End-Users in 2026
-
Table Kyushu Gene Therapy Consumption by Types from 2014 to 2026
-
Table Kyushu Gene Therapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2014
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2018
-
Figure Kyushu Gene Therapy Consumption Share by Types in 2026
-
Table Kyushu Gene Therapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu Gene Therapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2014
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2018
-
Figure Kyushu Gene Therapy Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Bluebird Bio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio
Figure Sales and Growth Rate Analysis of Bluebird Bio
Figure Revenue and Market Share Analysis of Bluebird Bio
Table Product and Service Introduction of Bluebird Bio
Table Company Profile and Development Status of Dimension Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Dimension Therapeutics
Figure Sales and Growth Rate Analysis of Dimension Therapeutics
Figure Revenue and Market Share Analysis of Dimension Therapeutics
Table Product and Service Introduction of Dimension Therapeutics
Table Company Profile and Development Status of Spark Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Spark Therapeutics
Figure Sales and Growth Rate Analysis of Spark Therapeutics
Figure Revenue and Market Share Analysis of Spark Therapeutics
Table Product and Service Introduction of Spark Therapeutics
Table Company Profile and Development Status of Sangamo
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sangamo
Figure Sales and Growth Rate Analysis of Sangamo
Figure Revenue and Market Share Analysis of Sangamo
Table Product and Service Introduction of Sangamo
Table Company Profile and Development Status of Avalanche Bio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Avalanche Bio
Figure Sales and Growth Rate Analysis of Avalanche Bio
Figure Revenue and Market Share Analysis of Avalanche Bio
Table Product and Service Introduction of Avalanche Bio
Table Company Profile and Development Status of Advantagene
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advantagene
Figure Sales and Growth Rate Analysis of Advantagene
Figure Revenue and Market Share Analysis of Advantagene
Table Product and Service Introduction of Advantagene
Table Company Profile and Development Status of Celladon
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celladon
Figure Sales and Growth Rate Analysis of Celladon
Figure Revenue and Market Share Analysis of Celladon
Table Product and Service Introduction of Celladon
Table Company Profile and Development Status of Vical Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical Inc.
Figure Sales and Growth Rate Analysis of Vical Inc.
Figure Revenue and Market Share Analysis of Vical Inc.
Table Product and Service Introduction of Vical Inc.
-
